BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 28379184)

  • 21. Berberine Inhibits Gluconeogenesis in Skeletal Muscles and Adipose Tissues in Streptozotocin-induced Diabetic Rats via LKB1-AMPK-TORC2 Signaling Pathway.
    Xu XH; Hu Q; Zhou LS; Xu LJ; Zou X; Lu FE; Yi P
    Curr Med Sci; 2020 Jun; 40(3):530-538. PubMed ID: 32681256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AMPK-dependent repression of hepatic gluconeogenesis via disruption of CREB.CRTC2 complex by orphan nuclear receptor small heterodimer partner.
    Lee JM; Seo WY; Song KH; Chanda D; Kim YD; Kim DK; Lee MW; Ryu D; Kim YH; Noh JR; Lee CH; Chiang JY; Koo SH; Choi HS
    J Biol Chem; 2010 Oct; 285(42):32182-91. PubMed ID: 20688914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nardostachys jatamansi DC Extract Alleviates Insulin Resistance and Regulates Glucose Metabolism in C57BL/KsJ-db/db Mice Through the AMP-Activated Protein Kinase Signaling Pathway.
    You HN; Park MH; Hwang SY; Han JS
    J Med Food; 2018 Apr; 21(4):324-331. PubMed ID: 29630449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of hepatic gluconeogenesis by nuclear factor Y transcription factor in mice.
    Zhang Y; Guan Q; Liu Y; Zhang Y; Chen Y; Chen J; Liu Y; Su Z
    J Biol Chem; 2018 May; 293(20):7894-7904. PubMed ID: 29530977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclocarya paliurus triterpenoids suppress hepatic gluconeogenesis via AMPK-mediated cAMP/PKA/CREB pathway.
    Cao J; Zheng R; Chang X; Zhao Y; Zhang D; Gao M; Yin Z; Jiang C; Zhang J
    Phytomedicine; 2022 Jul; 102():154175. PubMed ID: 35609386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adropin regulates hepatic glucose production via PP2A/AMPK pathway in insulin-resistant hepatocytes.
    Chen X; Chen S; Shen T; Yang W; Chen Q; Zhang P; You Y; Sun X; Xu H; Tang Y; Mi J; Yang Y; Ling W
    FASEB J; 2020 Aug; 34(8):10056-10072. PubMed ID: 32579277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Small molecule IVQ, as a prodrug of gluconeogenesis inhibitor QVO, efficiently ameliorates glucose homeostasis in type 2 diabetic mice.
    Zhou TT; Zhao T; Ma F; Zhang YN; Jiang J; Ruan Y; Yan QY; Wang GH; Ren J; Guan XW; Guo J; Zhao YH; Ye JM; Hu LH; Chen J; Shen X
    Acta Pharmacol Sin; 2019 Sep; 40(9):1193-1204. PubMed ID: 30833709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel FoxO1 inhibitor, JY-2, ameliorates palmitic acid-induced lipotoxicity and gluconeogenesis in a murine model.
    Choi HE; Kim Y; Lee HJ; Cheon HG
    Eur J Pharmacol; 2021 May; 899():174011. PubMed ID: 33705803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Geniposide Suppresses Hepatic Glucose Production via AMPK in HepG2 Cells.
    Guo L; Zheng X; Liu J; Yin Z
    Biol Pharm Bull; 2016; 39(4):484-91. PubMed ID: 26830672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ergostatrien-3β-ol from Antrodia camphorata inhibits diabetes and hyperlipidemia in high-fat-diet treated mice via regulation of hepatic related genes, glucose transporter 4, and AMP-activated protein kinase phosphorylation.
    Kuo YH; Lin CH; Shih CC
    J Agric Food Chem; 2015 Mar; 63(9):2479-89. PubMed ID: 25693659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Curcumin inhibits glucose production in isolated mice hepatocytes.
    Fujiwara H; Hosokawa M; Zhou X; Fujimoto S; Fukuda K; Toyoda K; Nishi Y; Fujita Y; Yamada K; Yamada Y; Seino Y; Inagaki N
    Diabetes Res Clin Pract; 2008 May; 80(2):185-91. PubMed ID: 18221818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of Bofu-Tsusho-San on diabetes and hyperlipidemia associated with AMP-activated protein kinase and glucose transporter 4 in high-fat-fed mice.
    Lin CH; Kuo YH; Shih CC
    Int J Mol Sci; 2014 Nov; 15(11):20022-44. PubMed ID: 25375187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ginsenoside Re lowers blood glucose and lipid levels via activation of AMP-activated protein kinase in HepG2 cells and high-fat diet fed mice.
    Quan HY; Yuan HD; Jung MS; Ko SK; Park YG; Chung SH
    Int J Mol Med; 2012 Jan; 29(1):73-80. PubMed ID: 21971952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of the novel Foxo1 inhibitor AS1708727 on plasma glucose and triglyceride levels in diabetic db/db mice.
    Tanaka H; Nagashima T; Shimaya A; Urano Y; Shimokawa T; Shibasaki M
    Eur J Pharmacol; 2010 Oct; 645(1-3):185-91. PubMed ID: 20655898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-451 Negatively Regulates Hepatic Glucose Production and Glucose Homeostasis by Targeting Glycerol Kinase-Mediated Gluconeogenesis.
    Zhuo S; Yang M; Zhao Y; Chen X; Zhang F; Li N; Yao P; Zhu T; Mei H; Wang S; Li Y; Chen S; Le Y
    Diabetes; 2016 Nov; 65(11):3276-3288. PubMed ID: 27495223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Uric acid-dependent inhibition of AMP kinase induces hepatic glucose production in diabetes and starvation: evolutionary implications of the uricase loss in hominids.
    Cicerchi C; Li N; Kratzer J; Garcia G; Roncal-Jimenez CA; Tanabe K; Hunter B; Rivard CJ; Sautin YY; Gaucher EA; Johnson RJ; Lanaspa MA
    FASEB J; 2014 Aug; 28(8):3339-50. PubMed ID: 24755741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ginsenoside Rg2 induces orphan nuclear receptor SHP gene expression and inactivates GSK3β via AMP-activated protein kinase to inhibit hepatic glucose production in HepG2 cells.
    Yuan HD; Kim DY; Quan HY; Kim SJ; Jung MS; Chung SH
    Chem Biol Interact; 2012 Jan; 195(1):35-42. PubMed ID: 22062806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. L-Arabinose suppresses gluconeogenesis through modulating AMP-activated protein kinase in metabolic disorder mice.
    Wang Y; Guan Y; Xue L; Liu J; Yang Z; Nie C; Yan Y; Liu S; Sun J; Fan M; Qian H; Ying H; Li Y; Wang L
    Food Funct; 2021 Mar; 12(4):1745-1756. PubMed ID: 33502423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Propionate suppresses hepatic gluconeogenesis via GPR43/AMPK signaling pathway.
    Yoshida H; Ishii M; Akagawa M
    Arch Biochem Biophys; 2019 Sep; 672():108057. PubMed ID: 31356781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unmetabolized fenofibrate, but not fenofibric acid, activates AMPK and inhibits the expression of phosphoenolpyruvate carboxykinase in hepatocytes.
    Murakami R; Murakami H; Kataoka H; Cheng XW; Takahashi R; Numaguchi Y; Murohara T; Okumura K
    Life Sci; 2010 Oct; 87(15-16):495-500. PubMed ID: 20849861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.